SCHEDULE 13G

Avalo Therapeutics, Inc.

Common Stock, par value $0.001 per share (the "Shares") · CUSIP: 05338F306

Event date: 2026-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Farallon Capital Management, L.L.C.

  Shares: 3,974,000 · Class: 7.4%

• Dapice Joshua J.

  Shares: 3,974,000 · Class: 7.4%

• Dreyfuss, Philip D.

  Shares: 3,974,000 · Class: 7.4%

• Dunn Hannah E.

  Shares: 3,974,000 · Class: 7.4%

• Gehani, Varun N.

  Shares: 3,974,000 · Class: 7.4%

• Giauque, Nicolas

  Shares: 3,974,000 · Class: 7.4%

• Husen, Avner A.

  Shares: 3,974,000 · Class: 7.4%

• Kim, David T.

  Shares: 3,974,000 · Class: 7.4%

• Linn, Michael G.

  Shares: 3,974,000 · Class: 7.4%

• Luo Patrick (Cheng)

  Shares: 3,974,000 · Class: 7.4%

• Roberts, Jr., Thomas G.

  Shares: 3,974,000 · Class: 7.4%

• Saito Edric C.

  Shares: 3,974,000 · Class: 7.4%

• Short Daniel S.

  Shares: 3,974,000 · Class: 7.4%

• Spokes, Andrew J. M.

  Shares: 3,974,000 · Class: 7.4%

• Warren, John R.

  Shares: 3,974,000 · Class: 7.4%

• Wehrly, Mark C.

  Shares: 3,974,000 · Class: 7.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.